Invivyd News

Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT) and Invivyd (IVVD)

TipRanksApr 8 12:10 ET

Invivyd Analyst Ratings

BenzingaApr 5 08:12 ET

Guggenheim Upgrades Invivyd to Buy, Announces $9 Price Target

BenzingaApr 5 08:13 ET

Invivyd Analyst Ratings

BenzingaMar 26 05:26 ET

Invivyd's PEMGARDA: Strong Buy Rating on FDA EUA and Strategic Market Positioning

TipRanksMar 25 09:05 ET

Invivyd Analyst Ratings

BenzingaMar 25 08:57 ET

Invivyd Analyst Ratings

BenzingaJan 18 06:14 ET

Invivyd Analyst Ratings

BenzingaDec 19, 2023 09:09 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: NeuroOne Medical Technologies (NMTC), Invivyd (IVVD) and Ligand Pharma (LGND)

TipRanksDec 18, 2023 09:31 ET

Buy Rating for Invivyd Due to Promising COVID-19 Therapy VYD222 and High Market Potential for Immunocompromised Populations

TipRanksNov 10, 2023 12:46 ET

Invivyd Analyst Ratings

BenzingaAug 14, 2023 06:19 ET

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target

BenzingaJul 18, 2023 04:13 ET

Invivyd Analyst Ratings

BenzingaJul 18, 2023 04:12 ET

H.C. Wainwright Remains a Buy on Invivyd (IVVD)

TipRanksJul 17, 2023 10:55 ET

H.C. Wainwright Sticks to Its Buy Rating for Invivyd (IVVD)

TipRanksJun 28, 2023 08:35 ET

What 4 Analyst Ratings Have To Say About Invivyd

BenzingaJun 23, 2023 11:01 ET

Analysts Offer Insights on NA Companies: Invivyd (IVVD) and ISun (ISUN)

TipRanksJun 23, 2023 06:20 ET

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target

BenzingaJun 23, 2023 06:12 ET

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target

BenzingaMay 15, 2023 10:09 ET

Invivyd (IVVD) Gets a Buy From H.C. Wainwright

TipRanksMay 15, 2023 06:15 ET